Published in Lancet on June 13, 2009
Tackling Africa's chronic disease burden: from the local to the global. Global Health (2010) 2.70
Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda. Int J Epidemiol (2010) 2.52
Epidemiology in Latin America and the Caribbean: current situation and challenges. Int J Epidemiol (2012) 1.93
Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemic. Am Heart J (2011) 1.22
Training and Capacity Building in LMIC for Research in Heart and Lung Diseases: The NHLBI-UnitedHealth Global Health Centers of Excellence Program. Glob Heart (2016) 1.17
The growing caseload of chronic life-long conditions calls for a move towards full self-management in low-income countries. Global Health (2011) 1.16
Noncommunicable chronic disease in Bangladesh: overview of existing programs and priorities going forward. Health Policy (2010) 1.15
Heart failure in sub-Saharan Africa. Curr Cardiol Rev (2013) 0.94
Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya. J Am Coll Cardiol (2015) 0.94
Rationale and design of the Primary pREvention strategies at the community level to Promote Adherence of treatments to pREvent cardiovascular diseases trial number (CTRI/2012/09/002981). Am Heart J (2013) 0.93
Research on health transition in Africa: time for action. Health Res Policy Syst (2011) 0.93
Understanding chronic non-communicable diseases in Latin America: towards an equity-based research agenda. Global Health (2011) 0.85
Cardiovascular health knowledge and preventive practices in people living with HIV in Kenya. BMC Infect Dis (2015) 0.85
Towards a better integration of global health and biodiversity in the new sustainable development goals beyond Rio+20. Ecohealth (2012) 0.84
Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL). Am Heart J (2015) 0.81
Implementation of management strategies for diabetes and hypertension: from local to global health in cardiovascular diseases. Glob Heart (2015) 0.78
Building a platform for translational research in chronic noncommunicable diseases to address population health: lessons from NHLBI supported CRONICAS in Peru. Glob Heart (2015) 0.76
The Importance of Global Health Experiences in the Development of New Cardiologists. J Am Coll Cardiol (2016) 0.75
Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure: A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya. Glob Heart (2016) 0.75
The United States and global health: inseparable and synergistic? The Institute of Medicine's report on global health. Glob Health Action (2009) 0.75
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66
BMJ Publishing Group to launch an international campaign to promote academic medicine. BMJ (2003) 11.51
A common open representation of mass spectrometry data and its application to proteomics research. Nat Biotechnol (2004) 11.42
Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project. Science (2010) 9.78
Scientific literature's open sesame? BMJ (2003) 7.92
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
How should we define health? BMJ (2011) 7.82
Closing the digital divide. BMJ (2003) 6.20
No more free lunches. BMJ (2003) 5.70
The GMC: expediency before principle. BMJ (2005) 5.66
FlyMine: an integrated database for Drosophila and Anopheles genomics. Genome Biol (2007) 5.23
Is the NHS getting better or worse? BMJ (2003) 5.04
What errors do peer reviewers detect, and does training improve their ability to detect them? J R Soc Med (2008) 4.92
Four futures for scientific and medical publishing. BMJ (2002) 4.51
The functional spectrum of low-frequency coding variation. Genome Biol (2011) 4.42
Take back your mink, take back your pearls. BMJ (2002) 4.36
Open access publishing takes off. BMJ (2004) 4.29
New BMJ policy on economic evaluations. BMJ (2002) 4.27
Effects of training on quality of peer review: randomised controlled trial. BMJ (2004) 4.20
Open letter to the leader of academic medicine. BMJ (2007) 4.06
Five futures for academic medicine. PLoS Med (2005) 3.95
Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A (2005) 3.49
The value of resident presentations at scientific meetings. Laryngoscope (2013) 3.48
Does declaration of competing interests affect readers' perceptions? A randomised trial. BMJ (2002) 3.44
Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ (2005) 3.35
Socioeconomic development as an intervention against malaria: a systematic review and meta-analysis. Lancet (2013) 3.22
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature (2007) 3.21
The discomfort of patient power. BMJ (2002) 3.19
Perceptions of open access publishing: interviews with journal authors. BMJ (2005) 2.85
Spend (slightly) less on health and more on the arts. BMJ (2002) 2.83
Reed-Elsevier's hypocrisy in selling arms and health. J R Soc Med (2007) 2.82
Is private health care the answer to the health problems of the world's poor? PLoS Med (2008) 2.82
Making progress with competing interests. BMJ (2002) 2.79
Are some diets "mass murder"? BMJ (2014) 2.73
The NHS in the simulator. BMJ (2009) 2.66
Too much medicine? BMJ (2002) 2.53
Big publishers cut access to journals in poor countries. Lancet (2011) 2.48
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol (2013) 2.43
The 1000 Genomes Project: data management and community access. Nat Methods (2012) 2.41
Patient safety requires a new way to publish clinical trials. PLoS Clin Trials (2006) 2.35
Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer (2009) 2.26
Lapses at the new England journal of medicine. J R Soc Med (2006) 2.22
Research misconduct: the poisoning of the well. J R Soc Med (2006) 2.16
Research misconduct in low- and middle-income countries. PLoS Med (2013) 2.08
A "fussy eater" with renal failure. Lancet (2010) 2.03
Consultant assessment and appraisal: an outline in practice. Clin Radiol (2002) 2.03
Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains. Nat Biotechnol (2005) 1.99
Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Mol Immunol (2007) 1.94
Global response to non-communicable disease. BMJ (2011) 1.93
Twenty thousand conversations. BMJ (2002) 1.91
A time for global health. BMJ (2002) 1.91
A POEM a week for the BMJ. BMJ (2002) 1.90
The BMJ: moving on. BMJ (2002) 1.88
The fallacy of impartiality: competing interest bias in academic publications. J R Soc Med (2009) 1.85
Does the type of competing interest statement affect readers' perceptions of the credibility of research? Randomised trial. BMJ (2004) 1.84
NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol Cancer Res (2006) 1.80
Dynamics of viremia in early hepatitis C virus infection. Transfusion (2005) 1.72
Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection. AIDS (2002) 1.70
What do we know about medical tourism? A review of the literature with discussion of its implications for the UK National Health Service as an example of a public health care system. J Travel Med (2014) 1.66
Editors' declaration of their own conflicts of interest. CMAJ (2004) 1.65
Photovoltaic Retinal Prosthesis with High Pixel Density. Nat Photonics (2012) 1.63
Death can be our friend. BMJ (2011) 1.62
Strategies for coping with information overload. BMJ (2010) 1.60
Should the capability approach be applied in health economics? Health Econ (2008) 1.58
Milton and Galileo would back BMJ on free speech. Nature (2004) 1.58
Medical tourism: a cost or benefit to the NHS? PLoS One (2013) 1.56
BMJ journals free to the developing world. BMJ (2002) 1.45
Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res (2002) 1.44
The 3rd DBCLS BioHackathon: improving life science data integration with Semantic Web technologies. J Biomed Semantics (2013) 1.44
The modENCODE Data Coordination Center: lessons in harvesting comprehensive experimental details. Database (Oxford) (2011) 1.39
Simon Stevens: the man charged with saving the NHS. BMJ (2014) 1.38
Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ (2007) 1.38
Perspective: a program to improve protein biomarker discovery for cancer. J Proteome Res (2005) 1.35
Analysis of factorial time-course microarrays with application to a clinical study of burn injury. Proc Natl Acad Sci U S A (2010) 1.33
Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion (2003) 1.32
The efficacy of oral nonsteroidal anti-inflammatory medication (NSAID) in the treatment of plantar fasciitis: a randomized, prospective, placebo-controlled study. Foot Ankle Int (2007) 1.30
What doctors and managers can learn from each other. BMJ (2003) 1.30
Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol (2011) 1.29
Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines. Lancet (2011) 1.27
Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab (2004) 1.23
Why do we need Cases Journal? Cases J (2008) 1.22
Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J Immunol Methods (2005) 1.17
EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma. Cancer Res (2009) 1.17
Provision of health information for all. BMJ (2011) 1.16
Doubts over head injury studies. BMJ (2007) 1.15
The social value of a QALY: raising the bar or barring the raise? BMC Health Serv Res (2011) 1.13
Global survey of diversity among environmental saltwater Bacteriovoracaceae. Environ Microbiol (2007) 1.13
Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour. Neuromolecular Med (2002) 1.11
The association of external knee adduction moment with biomechanical variables in osteoarthritis: a systematic review. Knee (2009) 1.11
Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol (2012) 1.11
Ambient particulate air pollution and ectopy--the environmental epidemiology of arrhythmogenesis in Women's Health Initiative Study, 1999-2004. J Toxicol Environ Health A (2009) 1.10
Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma. Head Neck (2006) 1.05
Nuclear war: preventable or inevitable? Br Med J (Clin Res Ed) (1984) 1.05
The use of fish cells in ecotoxicology. The report and recommendations of ECVAM Workshop 47. Altern Lab Anim (2004) 1.04
The BJGP. Br J Gen Pract (2012) 1.04
Global health priorities and research funding. Lancet Infect Dis (2013) 1.03
Functional analysis and treatment of self-injury in a captive olive baboon. J Appl Behav Anal (2009) 1.03
When to retract? BMJ (2003) 1.03